Beatty GL - Search Results

1

Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle.

Wattenberg MM, Beatty GL. Wattenberg MM, et al. Among authors: beatty gl. Semin Cancer Biol. 2020 Oct;65:38-50. doi: 10.1016/j.semcancer.2020.01.002. Epub 2020 Jan 15. Semin Cancer Biol. 2020. PMID: 31954172 Free PMC article. Review.

2

Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance.

Domchek SM, Recio A, Mick R, Clark CE, Carpenter EL, Fox KR, DeMichele A, Schuchter LM, Leibowitz MS, Wexler MH, Vance BA, Beatty GL, Veloso E, Feldman MD, Vonderheide RH. Domchek SM, et al. Among authors: beatty gl. Cancer Res. 2007 Nov 1;67(21):10546-55. doi: 10.1158/0008-5472.CAN-07-2765. Cancer Res. 2007. PMID: 17974999

3

Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.

Clark CE, Beatty GL, Vonderheide RH. Clark CE, et al. Among authors: beatty gl. Cancer Lett. 2009 Jun 28;279(1):1-7. doi: 10.1016/j.canlet.2008.09.037. Epub 2008 Nov 14. Cancer Lett. 2009. PMID: 19013709 Review.

4

Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH. Bayne LJ, et al. Among authors: beatty gl. Cancer Cell. 2012 Jun 12;21(6):822-35. doi: 10.1016/j.ccr.2012.04.025. Cancer Cell. 2012. PMID: 22698406 Free PMC article.

5

CD40 immunotherapy for pancreatic cancer.

Vonderheide RH, Bajor DL, Winograd R, Evans RA, Bayne LJ, Beatty GL. Vonderheide RH, et al. Among authors: beatty gl. Cancer Immunol Immunother. 2013 May;62(5):949-54. doi: 10.1007/s00262-013-1427-5. Epub 2013 Apr 16. Cancer Immunol Immunother. 2013. PMID: 23589109 Free PMC article. Review.

6

Immune escape mechanisms as a guide for cancer immunotherapy.

Beatty GL, Gladney WL. Beatty GL, et al. Clin Cancer Res. 2015 Feb 15;21(4):687-92. doi: 10.1158/1078-0432.CCR-14-1860. Epub 2014 Dec 12. Clin Cancer Res. 2015. PMID: 25501578 Free PMC article. Review.

7

Overcoming Therapeutic Resistance by Targeting Cancer Inflammation.

Beatty GL. Beatty GL. Am Soc Clin Oncol Educ Book. 2016;35:e168-73. doi: 10.1200/EDBK_158948. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249720 Free article. Review.

8

Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps.

Beatty GL, O'Hara M. Beatty GL, et al. Pharmacol Ther. 2016 Oct;166:30-9. doi: 10.1016/j.pharmthera.2016.06.010. Epub 2016 Jun 29. Pharmacol Ther. 2016. PMID: 27373504 Free PMC article. Review.

9

Functio Laesa: Cancer Inflammation and Therapeutic Resistance.

Liu M, Kalbasi A, Beatty GL. Liu M, et al. Among authors: beatty gl. J Oncol Pract. 2017 Mar;13(3):173-180. doi: 10.1200/JOP.2016.020347. J Oncol Pract. 2017. PMID: 28282278 Free PMC article. Review.

10

Deploying Immunotherapy in Pancreatic Cancer: Defining Mechanisms of Response and Resistance.

Beatty GL, Eghbali S, Kim R. Beatty GL, et al. Am Soc Clin Oncol Educ Book. 2017;37:267-278. doi: 10.1200/EDBK_175232. Am Soc Clin Oncol Educ Book. 2017. PMID: 28561678 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page